Updates are available Correction dated 2023-05-17
Click to view Correction: https://doi.org/10.1186/s13063-023-07342-9
-
Authors
Inoue, Kenji http://orcid.org/0000-0002-7193-8421
Chieh, Jack Tan Wei
Yeh, Lim Chiw
Chiang, Shuo-Ju
Phrommintikul, Arintaya
Suwanasom, Pannipa
Kasim, Sazzli
Ahmad, Bakhtiar
Idrose, Alzamani Mohammad
Salleh, Farina Mohd
Oyamada, Shunsuke
Hirano, Yohei
Ouchi, Shohei
Terakura, Moriyuki
Yokoyama, Naoyuki
Kozuma, Ken
Nanasato, Mamoru
Higuchi, Ryosuke
Yumoto, Kazuhiko
Fukuzawa, Tomoyuki
Shimada, Issei
Giannitsis, Evangelos
Twerenbold, Raphael
Minamino, Tohru
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Scientific Research (18K09954)
- License Information
-
More Information
Article History
Received: 26 March 2022
Accepted: 9 November 2022
First Online: 7 December 2022
Change Date: 17 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-023-07342-9
Declarations
:
: Prior to initiation, the study was approved by the Ethical Review Board of Juntendo University Nerima Hospital (reference number N20-0048). Ethical approval has been received from the local ethics committees. Written informed consent is obtained from all participating patients before inclusion. The consent is obtained by the attending doctor, nurse, or research assistant. The consent and randomization data are automatically saved in an encrypted server database.
: Dr. Inoue has received research grant from Grant-in-Aid for Scientific Research C, No. 18K09954), Roche Diagnostics, SB Bioscience Co., Ltd., Fujirebio Inc., Bayel Sysmex and Kanto Chemical Co. Inc.Dr. Twerenbold reports research support from the Swiss National Science Foundation (Grant No P300PB_167803), the Swiss Heart Foundation, the Swiss Society of Cardiology, the Cardiovascular Research Foundation Basel, the University of Basel, and the University Hospital Basel and speaker honoraria/consulting honoraria from Abbott, Amgen, Astra Zeneca, Roche, Siemens, Singulex, and Thermo Scientific BRAHMS.Dr. Giannitsis declares honoraria for lectures from Daiichi Sankyo, Astra Zeneca, Roche Diagnostics, Boehringer Ingelheim, Bayer Vital, and BRAHMS GmbH. He receives research funding from Daiichi Sankyo and Roche Diagnostics. He consults Roche Diagnostics, Astra Zeneca, Bayer Vital, Indorsia, Radiometer, BRAHMS GmbH, Hoffmann-La Roche, and Boehringer Ingelheim.Dr. JWCT has received honoraria from AstraZeneca, Bayer, Amgen, Medtronic, Abbott Vascular, Biosensors, Alvimedica, Boehringer Ingelheim, and Pfizer; research and educational grants from Medtronic, Biosensors, Biotronik, Philips, Amgen, AZ, Roche, Ostuka, Terumo, and Abbott Vascular; and consulting fees from Elixir, CSL Behring.Dr. Minamino has received research grant from Roche Diagnostics.
